Real-world evidence on the association between cardiac implantable electronic device infection and all-cause mortality
Open Access
- 2 August 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (9)
Abstract
Aims: An infection following cardiac implantable electronic device (CIED) procedure is a serious complication, but its association with all-cause mortality is inconsistent across observational studies. To quantify the association between CIED infection and all-cause mortality in a large, contemporary cohort from New South Wales, Australia. Methods and results: This retrospective cohort study used linked hospital and mortality data and included all patients aged >18 years who underwent a CIED procedure between July 2017 and September 2022. Cardiac implantable electronic device infection was defined by the presence of relevant diagnosis codes. Cox regression to estimate adjusted hazard ratios (aHRs) with 95% confidence intervals (CIs) for the association of CIED infection with mortality, at 1-year, and at the end of follow-up, with CIED infection included as a time-dependent variable, and other potential risk factors for mortality included as fixed covariates. We followed 37,750 patients with CIED procedures {36% female, mean age [standard deviation (SD)] 75.8 [12.7] years}, and 487 (1.3%) CIED infections were identified. We observed 5771 (15.3%) deaths during an average follow-up of 25.2 (SD 16.8) months. Compared with no infection group, patients with CIED infection had a higher Kaplan-Meier mortality rate (19.4 vs. 6.8%) and adjusted hazard of mortality (aHR 2.73, 95% CI 2.10−3.54) at 12 months post-procedure. These differences were attenuated but still remained significant at the end of follow-up (aHR 1.83, 95% CI 1.52−2.19). Conclusion: In a complete, state–wide cohort of CIED patients, infection was associated with higher risks of both short–term and long–term mortality.Keywords
Funding Information
- NHMRC (#APP11447430)
- Medtronic Australasia Pty Ltd
This publication has 9 references indexed in Scilit:
- REducing INFectiOns thRough Cardiac device Envelope: insight from real world data. The REINFORCE projectEP Europace, 2023
- Efficacy of the antibacterial envelope to prevent cardiac implantable electronic device infection in a high-risk populationEP Europace, 2022
- Prevention of cardiac implantable electronic device infections: guidelines and conventional prophylaxisEP Europace, 2021
- Impact of Cardiac Implantable Electronic Device InfectionCirculation: Arrhythmia and Electrophysiology, 2020
- European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections—endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)EP Europace, 2019
- 669No association between CIED infection and mortality: long-term follow up of a complete, nationwide cohort in DenmarkEP Europace, 2018
- Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE)Journal of Antimicrobial Chemotherapy, 2014
- Increased Long‐Term Mortality in Patients with Cardiovascular Implantable Electronic Device InfectionsPacing and Clinical Electrophysiology, 2014
- Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort studyHeart, 2012